NARODOWY INSTYTUT ZDROWIA PUBLICZNEGO-PANSTWOWY ZAKLAD HIGIENY [ NIPH-NIH ]

CHOCIMSKA 00791 WARSZAWA - Poland

Involved in the following projects during the 3rd programme

3rd Health Programme (2014-2020)
Innovative Partnership for Action Against Cancer [iPAAC]
The general objective of the Joint Action – Innovative Partnership for Action Against Cancer (iPAAC JA) is to develop innovative approaches to advances in cancer control. The innovation that will be...
The general objective of the Joint Action – Innovative Partnership for Action Against Cancer (iPAAC JA) is to develop innovative approaches to advances in cancer control. The innovation that will be covered within the JA consists of further development of cancer prevention, comprehensive approaches to the use of genomics in cancer control, cancer information and registries, improvements and challenges in cancer care, mapping of innovative cancer treatments and governance of integrated cancer control, including a new analysis of National Cancer Control Plans. The development of innovative approaches to cancer control will be supplemented by a Roadmap on Implementation and Sustainability of Cancer Control Actions, which will support Member States in implementation of iPAAC and CANCON recommendations. The Roadmap will act as the central pillar of the JA, integrating the diverse topic areas, providing synergies between the topics, ensuring consideration of transversal issues for all topics and acting as the central comprehensive deliverable, integrating all the JA outputs. A variety of methods will be used to fulfil the general and specific objectives including pilot studies, working groups, expert panels, literature review and surveys. A governmental board will be in place to ensure that implementation and sustainability in national contexts are duly considered for each topic area. The proposal for the iPAAC JA proposes actions to address objective 1 of the 2017 annual work programme, that is promoting health, preventing diseases and fostering supportive environments for healthy lifestyles taking into account the ‘health in all policies’ principle. The work to be developed by the iPAAC JA is complementary to the outcomes of the EPAAC and CANCON Joint Actions, funded by the Second and Third Health Programmes and will build on their outputs, using the stakeholder networks as an optimal base for the development of innovative cancer control actions.
Start date: 01/04/2018 - End date: 31/12/2021

Call: Joint Actions 2017
Topic: Joint Action — Innovative Partnership on Action against Cancer
3rd Health Programme (2014-2020)
Strengthened International HeAlth Regulations and Preparedness in the EU - Joint Action [SHARP JA]
The SHARP Joint Action will strengthen implementation of Decision 1082/2013/EU, supporting the EU level preparedness and responses to health threats and the implementation of the International Health ...
The SHARP Joint Action will strengthen implementation of Decision 1082/2013/EU, supporting the EU level preparedness and responses to health threats and the implementation of the International Health Regulations (2005). The Joint Action implements actions mentioned in Annex 1 of the Annual Work plan 2018 of the EU Health Programme 2014-2020.
Through the Joint Action, the member and partner states and the Unions common ability to prevent, detect and respond to biological outbreaks, chemical contamination and environmental and unknown threats to human health will be strengthened. Special efforts will be employed to fill gaps that have been or will be identified in priority countries (countries that have biggest gaps in the capacity required for full IHR capability). The Joint action consists of 10 Work Packages, covering core public health capacities according to the IHR (2005). In addition to a coordination function, these will cover areas such as Communication, Evaluation, Sustainability, IHR core capacity, Preparedness, Laboratories, Training and exercises, Chemical threats and Clinical management.
SHARP will also collaborate with several other Joint Actions, specifically the “Healthy Gateways” that addresses Points of Entry, the Joint Action on Vaccination (EU-JAV) and the Joint Action on Antimicrobial Resistance (EU-JAMRAI).
The partnership of the joint action consists of 26 Associated Partners and 33 Affiliated Entities, which all will receive Commission co-funding. In addition there are 9 Collaborating Partners that will self-fund all activities that they participate in. Totally 30 countries (24 EU members, 3 EEA/EFTA members and 3 European neighborhood countries) participate in the Joint Action. The SHARP JA will liaise with and collaborate with the ECDC, the WHO EURO regional office and the WHO Health Emergency and IHR unit in Lyon, and IANPHI in relevant activities. Special emphasis will be made to avoid duplication of work for the member states.

Start date: 01/04/2019 - End date: 31/03/2023

Call: Joint Actions 2018
Topic: Joint Action to strengthen preparedness including laboratories in the EU against serious cross-border threats to health and support the implementation of International Health Regula...
Topic: Joint Action to strengthen preparedness including laboratories in the EU against serious cross-border threats to health and support the implementation of International Health Regulations (IHR)
3rd Health Programme (2014-2020)
Preparedness and action at points of entry [Healthy GateWays]
The action aims at supporting cooperation and coordination of Member States (MS) to improve their capacities at points of entry (PoE) including ports, airports and ground crossings, in preventing and ...
The action aims at supporting cooperation and coordination of Member States (MS) to improve their capacities at points of entry (PoE) including ports, airports and ground crossings, in preventing and combating cross-border health threats from the transport sector. In future public health emergencies of international concern, the action will move from interepidemic mode to emergency mode supporting coherent response as per Decision No 1082/2013/EU, International Health Regulations and temporary recommendations. The action objectives will be achieved through: a) facilitating exchange of identified best practices for management of public health events, vector surveillance and control, contingency planning, validated preparedness and response plans and options for improved detection and surveillance of public health events at PoE; b) supporting MS in validating contingency plans by using assessment tools and conduct of tabletop/simulation exercises; c) providing distance and face-to-face training at local, national, European levels about contingency planning and management of events due to infections, vectors, chemical, environmental or other agents at PoE; d) supporting rapid information exchange through electronic tools by the established network for PoE; e) supporting execution of inspections on ships and airplanes; f) producing guidelines to be used by MS for dealing with chemical threats, inter-country communication and information flow in outbreak investigations and management of events on ships, for vector surveillance and control activities at PoE, for inspecting aircrafts and ships including their cargoes for vectors and auditing guidelines for hygiene inspections on ships; g) supporting intersectorial cooperation by promoting implementation of MoU among different sectors at PoE and organizing exchange of visits and exercises among PoE of neighbouring countries. The action falls under the thematic priority 2.2 of Annex I of the 2017 Annual Work Programme.
Start date: 01/05/2018 - End date: 30/04/2022

Call: Joint Actions 2017
Topic: Joint Action on preparedness and action at points of entry (air, maritime and ground crossing
3rd Health Programme (2014-2020)
Increased Access To Vaccination for Newly Arrived Migrants [AcToVax4NAM]
Increased Access to Vaccination for Newly Arrived Migrants (NAM)- AcToVax4NAM aims to improve vaccination access for NAM making access conditions equitable & guaranteed. The project responds to 2020 ...
Increased Access to Vaccination for Newly Arrived Migrants (NAM)- AcToVax4NAM aims to improve vaccination access for NAM making access conditions equitable & guaranteed. The project responds to 2020 WP’s specific topic “Increased access to vaccination for newly arrived migrants in first-line, transit & destination countries”. Objectives: (1) Describe immunization guidance, reception & vaccination offer systems for NAMs (2) Characterize system barriers hindering immunization of NAMs & identify possible solutions
-Reinforce networking capacity among institutional & non-institutional organizations & actors to address health literacy & cultural competency of the health care system with respect to NAM immunization. (3) Strengthen health literacy & responsiveness of organizations, health care professionals and other health operators (such as cultural mediators) to increase capacity building & cultural sensitivity of the health care system for promoting NAM’s active immunization (4) Develop country specific action-oriented flow charts to improve access to immunization comprising identified barriers & proposed solutions/tools/strategies validated by the target group (6) pilot test & evaluate country specific solutions to overcome system barriers emphasizing the life course approach, produce final recommendations & create networks of collaboration. AcToVax4NAM targets health and social care professionals and other related professionals such as mediators working with NAM. The final beneficiaries are NAMs. Expected results/outputs: (1) Updated knowledge on reception & vaccination systems/conceptual framework (2) Country specific information on system barriers & relevant solutions/logic flow charts/Database with tools (3) Capacity building to strengthen health literacy perspectives among target groups/related activities and training (4) Pilot testing solutions to overcome system barriers and demonstrate concrete and effective practices to increase coverage/Recommendations.
Start date: 01/05/2021 - End date: 30/04/2024

Call: Call for Proposals for Project Grants under the Annual Work Programme 2020 of the 3rd EU Health Programme
Topic: Stakeholder activities to support the implementation of the Council Recommendation on strengthened cooperation against vaccine-preventable diseases
3rd Health Programme (2014-2020)
Efficient response to highly dangerous and emerging pathogens at EU level [EMERGE]
The human population is confronted with emerging and re-emerging infectious pathogens that can cause serious cross-border outbreaks. A recent example is the Ebola outbreak requiring strong diagnostic,...
The human population is confronted with emerging and re-emerging infectious pathogens that can cause serious cross-border outbreaks. A recent example is the Ebola outbreak requiring strong diagnostic, clinical, and public health measures in Europe and abroad in order to get this incident under control. The JA EMERGE is in compliance with the European policy (Decision No 1082/2013/EU) where the need for an efficient, rapid and coordinated response to high threat pathogens is defined. The JA EMERGE comprises a European network with more then 40 diagnostic laboratories focused on risk group 3 bacteria and risk groups 3 and 4 viruses. It will act in a so-called inter-epidemic mode (IEM) which can be activated and switched into an outbreak response mode (ORM) on request by the Health Security Committee in order to direct all activities to the outbreak management. A number of other laboratory networks, institutions and agencies are contributing to the management of cross-border infectious outbreaks. EMERGE will provide a platform for establishment and consolidation of a common, coordinated and effective response to infectious disease outbreaks at EU level and abroad (WP4). State of the art and new diagnostic methods for high threat pathogens, including in-house and commercial kits, will be evaluated for their applicability and recommended in outbreak situations when suitable (WP5). External quality assurance exercises will ensure best approaches for laboratory responsiveness in outbreak situations (WP6). These activities must be supported by an appropriate training to share best practices of diagnostics and bio-risk management (WP7). In conclusion, the general objective will be to ensure efficient response to serious emergent and re-emergent cross-border events by reinforcing the existing EU network of BSL 3 and BSL 4 laboratories which are already active in the field of identification of dangerous bacterial and viral human pathogens.
Start date: 01/06/2015 - End date: 31/03/2019

Call: Grants for actions co-financed with Member State authorities 2014 (Joint Actions)
Topic: Pathogens Joint Action